Drugs / Bethametasone valerate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06887322 Comparator | Feb → Apr 2025 overdue | psoriasis | Padjadjaran University | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bethametasone valerate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06887322 ↗ |
| Route | Topical | “bethametasone valerate 0,1% cream, applied twice daily for 14 days.” NCT06887322 ↗ |